XML 43 R36.htm IDEA: XBRL DOCUMENT v3.19.1

Investment in Joint Venture (Tables)

12 Months Ended

Dec. 31, 2018

Investments accounted for using equity method [abstract]

Schedule of Joint Venture Share

The Company’s share of the joint venture consists of the following (in $000’s of USD):

Balance, January 1, 2018		$	15,727
Share of income for the year			2,381
Balance, December 31, 2018		$	18,108

Summary Financial Information Joint Venture

Summarized financial information of Pure Sunfarms (in $000’s of CAD):

		December 31, 2018				December 31, 2017
Current assets
Cash and cash equivalents		$	2,362			$	2,907
Trade receivables			1,312				—
Inventory			8,356				25
Biological asset			7,388				—
Other current assets			996				210
Non-current assets			67,263				23,384
Current liabilities
Trade payables			(9,361	)			(253	)
Due to joint venture partners			(26,523	)			—
Other current liabilities			(3,582	)			(918	)
Non-current liabilities			(2,688	)			—
Net assets		$	45,523			$	25,355
		December 31, 2018				December 31, 2017
Reconciliation of net assets:
Accumulated deficit		$	5,523			$	(645	)
Contributions from joint venture partners			40,000				26,000
Net assets		$	45,523			$	25,355
		Year Ended December 31, 2018				Year Ended December 31, 2017
Revenue		$	4,917			$	—
Cost of sales*			(1,542	)			—
Selling, general and administrative expenses			(3,386	)			(880	)
Change in fair value of bio-asset			8,785				—
Income (loss) from operations			8,774				(880	)
Interest expense, net			(97	)			—
Foreign exchange loss			(234	)			(4	)
Other income, net			24				—
Income (loss) before taxes			8,467				(884	)
(Provision for) recovery of income taxes			(2,298	)			239
Net income (loss)		$	6,169			$	(645	)

* Included in cost of sales is CA$276 (US$206) of amortization expense.

X

- Definition

The disclosure of joint ventures. [Refer: Joint ventures [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2018-01-01
-Paragraph 17
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2018-03-01&anchor=para_17_b&doctype=Standard
-URIDate 2018-03-16

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2018-01-01
-Paragraph 16
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IAS&num=27&date=2018-03-01&anchor=para_16_b&doctype=Standard
-URIDate 2018-03-16

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2018-01-01
-Paragraph B4
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2018-03-01&anchor=para_B4_b&doctype=Appendix&seq=2
-URIDate 2018-03-16

+ Details

Name:	ifrs-full_DisclosureOfJointVenturesExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The disclosure of the reconciliation of the summarised financial information of a joint venture accounted for using the equity method to the carrying amount of the reporting entity's interest in the joint venture. [Refer: Carrying amount [member]; Joint ventures [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2018-01-01
-Paragraph B14
-Subparagraph b
-URI http://eifrs.ifrs.org/eifrs/XBRL?type=IFRS&num=12&date=2018-03-01&anchor=para_B14_b&doctype=Appendix&seq=2
-URIDate 2018-03-16

+ Details

Name:	ifrs-full_DisclosureOfReconciliationOfSummarisedFinancialInformationOfJointVentureAccountedForUsingEquityMethodToCarryingAmountOfInterestInJointVentureExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_InvestmentsAccountedForUsingEquityMethodAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration